These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36612072)

  • 41. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
    Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncologic management of hereditary colorectal cancer.
    Yacoub G; Nagalla S; Aklilu M
    Clin Colon Rectal Surg; 2012 Jun; 25(2):118-22. PubMed ID: 23730227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.
    Baudhuin LM; Burgart LJ; Leontovich O; Thibodeau SN
    Fam Cancer; 2005; 4(3):255-65. PubMed ID: 16136387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic application of hMLH1 methylation in hereditary non-polyposis colorectal cancer.
    Matsubara N
    Dis Markers; 2004; 20(4-5):277-82. PubMed ID: 15528793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.
    Schwartz CJ; da Silva EM; Marra A; Gazzo AM; Selenica P; Rai VK; Mandelker D; Pareja F; Misyura M; D'Alfonso TM; Brogi E; Drullinsky P; Razavi P; Robson ME; Drago JZ; Wen HY; Zhang L; Weigelt B; Shia J; Reis-Filho JS; Zhang H
    Clin Cancer Res; 2022 Jan; 28(2):404-413. PubMed ID: 34667028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary.
    Kóder G; Olasz J; Tanyi JL; George E; Tóth L; Antal-Szalmás P; Nagy B; Bubán T; András C; Urbancsek H; Laczik M; Csuka O; Damjanovich L; Tanyi M
    J Gastrointest Cancer; 2020 Sep; 51(3):1007-1015. PubMed ID: 31939059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study.
    Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C;
    BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome.
    Martín-López JV; Fishel R
    Fam Cancer; 2013 Jun; 12(2):159-68. PubMed ID: 23572416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
    Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
    Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA-like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses.
    Xu Y; Li C; Wang Z; Liu F; Xu Y
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1359. PubMed ID: 32548945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lynch or not Lynch? Is that always a question?
    Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
    Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population.
    Yamamoto A; Yamaguchi T; Suzuki O; Ito T; Chika N; Kamae N; Tamaru JI; Nagai T; Seki H; Arai T; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2021 Jan; 51(1):60-69. PubMed ID: 32844218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians.
    Sijmons RH; Greenblatt MS; Genuardi M
    Fam Cancer; 2013 Jun; 12(2):181-7. PubMed ID: 23525798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
    Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
    Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for presence of mismatch repair gene expression positive Lynch syndrome cases in India.
    Bashyam MD; Kotapalli V; Raman R; Chaudhary AK; Yadav BK; Gowrishankar S; Uppin SG; Kongara R; Sastry RA; Vamsy M; Patnaik S; Rao S; Dsouza S; Desai D; Tester A
    Mol Carcinog; 2015 Dec; 54(12):1807-14. PubMed ID: 25420488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome.
    Liu Q; Thompson BA; Ward RL; Hesson LB; Sloane MA
    Hum Mutat; 2016 May; 37(5):417-26. PubMed ID: 26888055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.